Tenofovir DF vs. Adefovir Dipivoxil Chronic Hepatitis
ID Number 05-0594
Principal Investigator(s)Joseph A. Odin
Department(s) or Division(s)
Liver Diseases
Description
The purpose of this study is to compare the safety and the effectiveness of tenofovir DF (TDF) to that of adefovir dipivoxil (ADV) in patients chronically infected with hepatitis B virus (HBV).
Contact Information
Joseph A. Odin, MD
joseph.odin@mountsinai.org
Recruiting Patients: No